A drug from the Japanese Eisai and the American Biogen shows promising results in slowing the cognitive decline associated with Alzheimer’s. However, the consensus is not complete: some see it as a revolutionary advance, while others believe that the impact on the daily life of patients might not be as significant. We explain to them.
#Health #lights #shadows #promise #lecanemab #drug #Alzheimers
Karting | Robin Räikkönen, 9, won the championship in Switzerland
Karting|Robin Räikkönen was happy about his recent championship in the traditional way.Formula number one world champion Kimi Räikkönen son Robin...